118 related articles for article (PubMed ID: 24214827)
21. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
[TBL] [Abstract][Full Text] [Related]
22. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
[TBL] [Abstract][Full Text] [Related]
23. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
24. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.
Gillmore R; Stuart S; Kirkwood A; Hameeduddin A; Woodward N; Burroughs AK; Meyer T
J Hepatol; 2011 Dec; 55(6):1309-16. PubMed ID: 21703196
[TBL] [Abstract][Full Text] [Related]
25. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
[TBL] [Abstract][Full Text] [Related]
26. Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
Sahu S; Schernthaner R; Ardon R; Chapiro J; Zhao Y; Sohn JH; Fleckenstein F; Lin M; Geschwind JF; Duran R
Radiology; 2017 Jun; 283(3):883-894. PubMed ID: 27831830
[TBL] [Abstract][Full Text] [Related]
27. Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE.
Chai B; Xiang D; Wang W; Ren Y; Wang F; Wang J; Zhou G; Zheng C
Cancer Imaging; 2022 Jul; 22(1):38. PubMed ID: 35908071
[TBL] [Abstract][Full Text] [Related]
28. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
[TBL] [Abstract][Full Text] [Related]
29. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
[TBL] [Abstract][Full Text] [Related]
30. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
[TBL] [Abstract][Full Text] [Related]
31. Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma.
Seyal AR; Gonzalez-Guindalini FD; Arslanoglu A; Harmath CB; Lewandowski RJ; Salem R; Yaghmai V
Hepatology; 2015 Oct; 62(4):1111-21. PubMed ID: 25999236
[TBL] [Abstract][Full Text] [Related]
32. [The efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma according to extrahepatic collateral feeding vessels].
Jang BK; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Choi JS; Kwon JH
Korean J Hepatol; 2005 Dec; 11(4):359-70. PubMed ID: 16380665
[TBL] [Abstract][Full Text] [Related]
33. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response.
Joo I; Lee JM; Kim KW; Klotz E; Han JK; Choi BI
Eur J Radiol; 2011 Dec; 80(3):e278-83. PubMed ID: 21251785
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
35. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.
Miyaki D; Aikata H; Kan H; Fujino H; Urabe A; Masaki K; Fukuhara T; Kobayashi T; Naeshiro N; Nakahara T; Kawaoka T; Hiramatsu A; Takahashi S; Ishikawa M; Kakizawa H; Awai K; Chayama K
J Gastroenterol Hepatol; 2013 Dec; 28(12):1834-41. PubMed ID: 23808713
[TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
[TBL] [Abstract][Full Text] [Related]
38. Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
Chapiro J; Duran R; Lin M; Schernthaner R; Lesage D; Wang Z; Savic LJ; Geschwind JF
Eur Radiol; 2015 Jul; 25(7):1993-2003. PubMed ID: 25636420
[TBL] [Abstract][Full Text] [Related]
39. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of prognostic factors in patients with hepatocellular cancer treated by hepatic arterial infusion chemotherapy].
Izumi R; Shimizu K; Yabushita K; Watanabe T; Horichi H; Kitabayashi K; Tani T; Urade M; Iyobe T; Segawa M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2965-8. PubMed ID: 2551236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
